Showing results (1711-1720 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AMG 853, a CRTH2 and DP Dual AntagonistJiwen Liu, An-Rong Li, Yingcai Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design, Synthesis, and Antitumor Activity of 4-Halocolchicines and Their Pro-drugs Activated by Cathepsin BNaoko Yasobu, Mariko Kitajima, Noriyuki Kogure, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1Robert L Dow, Jian-Cheng Li, Michael P Pence, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Bisdionin C-a rationally designed, submicromolar inhibitor of family 18 chitinasesAlexander W Schüttelkopf, Ole A Andersen, Francesco V Rao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of EpilepsyGeorge Amato, Rosemarie Roeloffs, Greg C Rigdon, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Target Flexibility in RNA-Ligand Docking Modeled by Elastic Potential GridsDennis M Krüger, Johannes Bergs, Sina Kazemi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicityKonstantin Chegaev, Chiara Riganti, Loretta Lazzarato, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as β-Amyloid PET Ligands and Identification of MK-3328Scott T Harrison, James Mulhearn, Scott E Wolkenberg, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosidesElinor Breiner-Goldstein, Zoharia Evron, Michael Frenkel, et al.
Pageof 438